Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 71,957 | 56,566 | 57,570 | 63,287 | 38,781 |
| Cost of Goods | 215 | 4,553 | 3,557 | 4,471 | 6,721 |
| Gross Profit | 71,742 | 52,013 | 54,013 | 58,816 | 32,060 |
| Operating Expenses | 177,066 | 181,546 | 182,551 | 183,494 | 182,580 |
| Operating Income | -105,109 | -128,980 | -127,981 | -124,207 | -149,799 |
| Interest Expense | 5,170 | 3,808 | 3,996 | 5,819 | 8,371 |
| Other Income | -578 | -728 | -626 | 986 | 560 |
| Pre-tax Income | -110,857 | -133,516 | -132,603 | -129,040 | -157,610 |
| Income Tax | 61 | 197 | 190 | 520 | 1,036 |
| Net Income Continuous | -110,918 | -133,713 | -132,793 | -129,560 | -158,646 |
| Net Income | $-110,918 | $-133,713 | $-132,793 | $-129,560 | $-158,646 |
| EPS Basic Total Ops | -1.83 | -2.20 | -2.19 | -2.15 | -2.65 |
| EPS Basic Continuous Ops | -1.82 | -2.20 | -2.19 | -2.15 | -2.65 |
| EPS Diluted Total Ops | -1.83 | -2.20 | -2.19 | -2.15 | -2.65 |
| EPS Diluted Continuous Ops | -1.82 | -2.20 | -2.19 | -2.15 | -2.65 |
| EPS Diluted Before Non-Recurring Items | -1.82 | -2.20 | -2.19 | N/A | N/A |
| EBITDA(a) | $-109,517 | $-131,545 | $-128,113 | $-122,903 | $-144,609 |